
Hanmi’s Rosuzet ‘excellent in managing LDL-C in stent insertion patients’
Hanmi Pharm's Rosuz, a new combination drug treating dyslipidemia, has shown greater clinical usefulness than high-intensity statin monotherapy in a series of studies published in international journals. Hanmi said Thursday that “eClinicalMedicine,” a …